Doctor Critical of Vaccines Quietly Appointed as C.D.C.’s Second in Command

Dr. Ralph Lee Abraham’s Appointment Raises Concerns

During the Covid-19 pandemic, Dr. Ralph Lee Abraham supported the use of widely debunked treatments such as ivermectin and expressed skepticism toward vaccines. Despite these controversies, he has been appointed as the second in command at the Centers for Disease Control and Prevention (CDC), prompting concern among public health officials.

Background and Previous Roles

Dr. Abraham, a former congressman and Louisiana’s surgeon general, was previously involved in promoting alternative Covid treatments not endorsed by major health agencies. As a political figure, he often aligned with policies and rhetoric questioning federal health mandates.

Reaction from the Medical Community

Several public health experts have expressed unease about his appointment. They cite his past promotion of unverified therapies and his critical stance toward vaccination campaigns as potential risks for the agency’s credibility. One anonymous official noted that “placing someone with a record of disputing vaccine efficacy in a leadership role could erode public trust.”

Official Response and Statements

A CDC spokesperson confirmed the appointment but declined to comment on internal discussions leading to the decision. Supporters of Dr. Abraham argue that his experience in rural health and government could broaden the agency’s outreach and help connect with vaccine-hesitant populations.

“Dr. Abraham brings firsthand knowledge of communities that feel marginalized by public health authorities,” said a senior administration official.

Critics, however, warn that the move could politicize the CDC at a time when rebuilding trust in the agency remains a national priority.

Author’s summary: The CDC’s quiet appointment of vaccine critic Ralph Abraham as deputy director has sparked debate over trust, policy direction, and the future of public health leadership.

more

The New York Times The New York Times — 2025-11-28

More News